Administration of the 2,4-dinitrophenyl (Dnp) determinant conjugated to the "nonimmunogenic" copolymer of D-glutamic acid and D-lysine (D-GL) induces Dnp-specific immunological tolerance which is essentially restricted to bone marrow-derived ( 
The capacity to induce specific immunological tolerance that is essentially restricted to bone marrow-derived (B) lymphocytes of an individual has far-reaching clinical therapeutic potential. The successful induction of true hapten-specific tolerance in vivo by several investigators (1) (2) (3) (4) (5) (6) (7) may, indeed, reflect such a state of restricted B-cell tolerance (for review, see ref. 8 ). We have made extensive studies in a model of 2,4-dinitrophenyl (Dnp)-specific tolerance in inbred guinea pigs (1) , and more recently in mice (5) , in which tolerance was readily induced by treatment of such animals with a "nonimmunogenic" Dnp conjugate of the copolymer of D-glutamic acid and D-lysine (D-GL). Animals treated with Dnp-D-GL manifested profound Dnp-specific tolerance as reflected by their inability to respond to immunization with immunogenic Dnp-protein conjugates. The tolerant state in this model has been clearly shown to be expressed predominantly in the population of Dnp-specific B-lymphocyte precursors of antibody-forming cells, and has therefore been interpreted by us to reflect a central mechanism (1, 5, 8 , and see Discussion).
The studies cited above (1) (2) (3) (4) (5) (6) (7) (9) . All animals were bled on days 13 and 20 after priming and their sera analyzed for anti-Dnp antibodies.
As shown in Table 1 , untreated control mice in group A manifested significant IgE and IgG anti-Dnp antibody levels on days 13 and 20 after primary immunization with Dnp-ASC. Previous studies have documented that the peak IgE antibody titer is reached on day 20 after priming in this fashion (9) . In contrast, mice pretreated with Dnp-D-GL before primary immunization (group B) developed significantly lower anti-Dnp antibody responses in both IgE and IgG antibody classes. It is notable that the degree of suppression resulting from such pretreatment appears to be somewhat greater in the IgG than in the IgE antibody class. However, this finding probably reflects the fact that in this experiment PCA reactions were elicited with avery high dose (5O/sg) of test antigen (Dnp-BGG), thus allowing detection of both low-and high-affinity antibody molecules. The conditions of the Farr assay used to measure IgG antibodies, on the other hand, are such that predominantly moderate-to-high affinity molecules are detected. Since recent studies have demonstrated a preferential depression of the response of high-affinity IgG anti-Dnp antibody in the Dnp-D-GL model (18) , it is probable that the results obtained reflect these differences in affinity. This question is investigated in more detail in a subsequent section below.
Induction of Dnp-Specific Tolerance with Dnp-D-GL in an Adoptive Cell Transfer System. The relative ease with which Dnp-specific tolerance can be induced by Dnp-D-GL in a previously immunized animal (1) enabled us to develop a system for induction of tolerance in an adoptive transfer system in mice (5) . In the latter studies we were dealing with anti-Dnp responses of the IgG antibody class (5) . The more recent development in our laboratory of a system that uses suitably primed donor cells (9, 10) to such a system is the obviation of any contribution of circulating antibodies present in a primed intact animal, and the ability to delineate the longevity of the tolerant state by using serial cell transfer techniques.
In the first experiment of this type ( A second experiment (Fig. 2 ) was designed to determine to what extent secondary challenge in donor mice before cell transfer would affect the tolerant state demonstrable in adoptive cell recipients. Thus, 25 days after priming, A/J mice primed with Dnp-ASC were either treated or not with Dnp-D-GL as in the preceding experiment. 1 Week later, these two groups of mice were secondarily challenged with Dnp-ASC. 7
Days thereafter all mice were bled, and their spleen cells were removed and transferred to groups of irradiated syngeneic recipients. All recipients were given a final challenge with Dnp-ASC plus alum and then bled 7 days later.
The top panel of Fig. 2 illustrates the anti-Dnp antibody levels in the two groups of donor mice on day 7 after secondary challenge. Note the virtual abrogation of both IgE and IgG antibody responses in mice treated with Dnp-D-GL as contrasted to the untreated controls. The maintenance of this tolerant state after adoptive transfer of such cells to irradiated recipients is depicted in the bottom panel of Fig. 2 , thus corroborating the results of the preceding experiment (Fig. 1) . The amount of IgE antibody in the irradiated recipients of tolerant donor cells was slightly higher than in the tolerant donors. This finding probably reflects a combination of nonspecific proliferative stimuli in an irradiated environment, and the absence of circulating Dnp-D-GL, which may bind to a small proportion of residual antiDnp antibodies in the tolerant donors.
Preferential (Fig. 2) .
We have previously presented detailed evidence in the Dnp-D-GL model for a central mechanism of tolerance which is expressed predominantly in the population of Dnp-specific antibody-forming cells and their precursors, i.e., B lymphocytes. This conclusion is derived from the following findings:
(i) The tolerance induced by Dnp-D-GL is hapten-specific and the frequency of both antigen-binding lymphocytes specific for Dnp and cells forming antibodies to Dnp is significantly lower in tolerant animals than in normal or immune animals (1, 18) .
(ii) A very marked depression both in plaque-forming cells secreting high-affinity anti-Dnp antibody and in serum antibody of high affinity for Dnp has previously been shown to exist in IgG class responses in this model, indicating a preferential induction of tolerance in precursor cells bearing highaffinity receptors (18) . Evidence obtained in the present studies indicates that this is also the case in B lymphocytes of the IgE antibody class (Table 2) . ( iii) The absence of T-cell participation in the process of tolerance induction by Dnp-D-GL has been shown conclusively in very recent in vitro studies using lymphocytes from congenitally athymic (nude) mice (19) .
Recent studies from our laboratory designed to probe the questions of mechanism of induction of tolerance and fate of tolerant cells in the Dnp-D-GL model led us to conclude that the Dnp-specific tolerance induced in this way is an example of irreversible inhibition of cell reactivity to antigen reflecting yet-to-be-determined events at the intra-and subcellular level (5) . These intracellular events, we believe, are the ultimate and apparently irrevocable (for a given cell) consequence of a tolerogenic signal generated at the cell-surface membrane after binding of Dnp-D-GL to specific immunoglobulin receptors (there is no reason to believe that it is necessary for Dnp-D-GL to enter the cell in order for induction of tolerance to occur). These conclusions were Proc. Nat. Acad. Sci. USA 70 (1978) Proc. Nat. Acad. Sci. USA 70 (1973) servation indicates that during a short time after the binding of the tolerogenic molecule Dnp-D-GL, the specific B lymphocytes are activated and therefore susceptible to induction for differentiation and antibody production provided an appropriate T-cell signal is exerted. This period of activation is, however, extremely short and is followed by complete refractoriness.
Although the above findings and conclusions derive from studies on IgG antibody class responses, there is no evidence to suggest that similar (or identical) molecular events do not also occur in the induction of tolerance in B lymphocytes of the IgE class. Indeed, certain features such as the capacity to induce tolerance in previously primed lymphocytes and maintenance of unresponsiveness after adoptive transfer have been shown in the present studies to occur for both antibody classes. Nevertheless, even if there are slight mechanistic differences between the two classes, the observations reported here represent the first demonstration of restricted Bcell tolerance of the IgE antibody class, and provide therefore a starting point for many areas of experimentation ultimately destined to solve many therapeutic problems concerning clinically allergic patients.
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